The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis

Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

Gautier JF, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity. 2020;28(5):848.

Article  CAS  PubMed  Google Scholar 

Delikhoon M, Guzman MI, Nabizadeh R, Norouzian BA. Modes of transmission of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and factors influencing on the airborne transmission: a review. Int J Environ Res Public Health. 2021;18(2):395.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alimohammadi M, Abolli S, Ghordouei ME. Perceiving effect of environmental factors on prevalence of SARS-Cov-2 virus and using health strategies: a review. J Adv Environ Health Res. 2022;10(3):187–96.

Article  Google Scholar 

Li XZ, Jin F, Zhang JG, Deng YF, Shu W, Qin JM, et al. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect Dis Poverty. 2020;9(1):78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin H, Wang H, Li X, Zheng W, Ye S, Zhang S, et al. Economic burden of COVID-19, China, January–March, 2020: a cost-of-illness study. Bull World Health Organ. 2021;99(2):112.

Article  PubMed  Google Scholar 

Bartsch SM, Ferguson MC, McKinnell JA, O'Shea KJ, Wedlock PT, Siegmund SS, et al. The potential health care costs and resource use associated with COVID-19 in the United States. Health Aff (Millwood). 2020;39(6):927–35.

Article  PubMed  Google Scholar 

Juranek S, Paetzold J, Winner H, Zoutman F. Labor market effects of COVID-19 in Sweden and its neighbors: evidence from novel administrative data. NHH Dept of Business and Management Science Discussion Paper. (2020/8); 2020.

Google Scholar 

Maltezou H, Giannouchos T, Pavli A, Tsonou P, Dedoukou X, Tseroni M, et al. Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis. J Hosp Infect. 2021;114:126–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faramarzi A, Javan-Noughabi J, Tabatabaee SS, Najafpoor AA, Rezapour A. The lost productivity cost of absenteeism due to COVID-19 in health care workers in Iran: a case study in the hospitals of Mashhad University of Medical Sciences. BMC Health Serv Res. 2021;21(1):1169.

Article  PubMed  PubMed Central  Google Scholar 

Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L, et al. Economic burden of COVID-19: a systematic review. Clinicoecon Outcomes Res. 2022;14:293–307.

Article  PubMed  PubMed Central  Google Scholar 

Forsythe S, Cohen J, Neumann P, Bertozzi SM, Kinghorn A. The economic and public health imperatives around making potential coronavirus disease–2019 treatments available and affordable. Value Health. 2020;23(11):1427–31.

Article  PubMed  PubMed Central  Google Scholar 

Rodela TT, Tasnim S, Mazumder H, Faizah F, Sultana A, Hossain MM. Economic impacts of coronavirus disease (COVID-19) in developing countries; 2020.

Book  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group* t. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.

Article  PubMed  Google Scholar 

Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011;29:653–71.

Article  PubMed  Google Scholar 

Konnopka A, König H. Economic burden of anxiety disorders: a systematic review and meta-analysis. Pharmacoeconomics. 2020;38:25–37.

Article  PubMed  Google Scholar 

Jeck J, Jakobs F, Kron A, Franz J, Cornely OA, Kron F. A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital. Infection. 2022;50(1):191–201.

Article  CAS  PubMed  Google Scholar 

Kotwani P, Patwardhan V, Pandya A, Saha S, Patel GM, Jaiswal S, et al. Valuing out-of-pocket expenditure and health related quality of life of COVID-19 patients from Gujarat, India. J Commun Dis (E-ISSN: 2581-351X & P-ISSN: 0019-5138). 2021;53(1):104–9.

Google Scholar 

Tsai Y, Vogt TM, Zhou F. Patient characteristics and costs associated with COVID-19–related medical care among Medicare fee-for-service beneficiaries. Ann Intern Med. 2021;174(8):1101–9.

Article  PubMed  Google Scholar 

Weiner JP, Bandeian S, Hatef E, Lans D, Liu A, Lemke KW. In-person and telehealth ambulatory contacts and costs in a large US insured cohort before and during the COVID-19 pandemic. JAMA Netw Open. 2021;4(3):e212618-e.

Article  Google Scholar 

Di Fusco M, Shea KM, Lin J, Nguyen JL, Angulo FJ, Benigno M, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308–17.

Article  PubMed  Google Scholar 

Edoka I, Fraser H, Jamieson L, Meyer-Rath G, Mdewa W. Inpatient care costs of COVID-19 in South Africa’s public healthcare system. Int J Health Policy Manag. 2022;11(8):1354.

PubMed  Google Scholar 

Tabuñar SM, Dominado TM. Hospitalization expenditure of COVID-19 patients at the university of the Philippines-Philippine general hospital (UP-PGH) with PhilHealth coverage. Acta Med Philipp. 2021;55(2)

Zhao J, Yao Y, Lai S, Zhou X. Clinical immunity and medical cost of COVID-19 patients under grey relational mathematical model. Results Phys. 2021;22:103829.

Article  PubMed  PubMed Central  Google Scholar 

Ghaffari Darab M, Keshavarz K, Sadeghi E, Shahmohamadi J, Kavosi Z. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran. BMC Health Serv Res. 2021;21(1):1–7.

Article  Google Scholar 

Barasa E, Kairu A, Maritim M, Were V, Akech S, Mwangangi M. Examining unit costs for COVID-19 case management in Kenya. BMJ Glob Health. 2021;6(4):e004159.

Article  PubMed  Google Scholar 

Seon J-Y, Jeon W-H, Bae S-C, Eun B-L, Choung J-T, Oh I-H. Characteristics in pediatric patients with coronavirus disease 2019 in Korea. J Korean Med Sci. 2021;36(20):e148.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banke-Thomas A, Makwe CC, Balogun M, Afolabi BB, Alex-Nwangwu TA, Ameh CA. Utilization cost of maternity services for childbirth among pregnant women with coronavirus disease 2019 in Nigeria’s epicenter. Int J Gynaecol Obstet. 2021;152(2):242–8.

Article  CAS  PubMed  Google Scholar 

Li X-Z, Jin F, Zhang J-G, Deng Y-F, Shu W, Qin J-M, et al. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect Dis Poverty. 2020;9(03):31–8.

CAS  Google Scholar 

Kirigia JM, Muthuri RNDK. The fiscal value of human lives lost from coronavirus disease (COVID-19) in China. BMC Res Notes. 2020;13:1–5.

Article  Google Scholar 

Lee JK, Kwak BO, Choi JH, Choi EH, Kim J-H, Kim DH. Financial burden of hospitalization of children with coronavirus disease 2019 under the national health insurance service in Korea. J Korean Med Sci. 2020;35(24):e224.

Article  PubMed  PubMed Central  Google Scholar 

Khan AA, AlRuthia Y, Balkhi B, Alghadeer SM, Temsah M-H, Althunayyan SM, et al. Survival and estimation of direct medical costs of hospitalized COVID-19 patients in the Kingdom of Saudi Arabia. Int J Environ Res Public Health. 2020;17(20):7458.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mas Romero M, Avendaño Céspedes A, Tabernero Sahuquillo MT, Cortés Zamora EB, Gómez Ballesteros C, Sánchez-Flor Alfaro V, et al. COVID-19 outbreak in long-term care facilities from Spain. Many lessons to learn. PLoS One. 2020;15(10):e0241030.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen NT, Sullivan B, Sagebin F, Hohmann SF, Amin A, Nahmias J. Analysis of COVID-19 patients with acute respiratory distress syndrome managed with extracorporeal membrane oxygenation at US academic centers. Ann Surg. 2021;274(1):40.

Article  PubMed  Google Scholar 

Viscusi WK. Economic lessons for COVID-19 pandemic policies. South Econ J. 2021;87(4):1064–89.

Article  PubMed  PubMed Central  Google Scholar 

Santos HLPC, Maciel FBM, Santos Junior GM, Martins PC, Prado NMBL. Public expenditure on hospitalizations for COVID-19 treatment in 2020, in Brazil. Rev Saude Publica. 2021;55:52.

Article  PubMed  PubMed Central  Google Scholar 

Zhao J, Jin H, Li X, Jia J, Zhang C, Zhao H, et al. Disease burden attributable to the first wave of COVID-19 in China and the effect of timing on the cost-effectiveness of movement restriction policies. Value Health. 2021;24(5):615–24.

Article  PubMed  PubMed Central  Google Scholar 

John D, Narassima M, Menon J, Rajesh JG, Banerjee A. Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021;11(8):e049619.

Article  PubMed  Google Scholar 

Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12):4233.

Article  CAS  PubMed 

Comments (0)

No login
gif